| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6022106 | Neurobiology of Disease | 2014 | 6 Pages |
Abstract
Five-AV markedly reduces the number of seizures initially and suppresses the development of the most severe type of seizures in the MSO model of MTLE. These results may have implications for the therapeutic use of 5-AV in treating mesial temporal lobe seizures and for our understanding of the chemical pathology of epileptogenesis and MTLE.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Roni Dhaher, Eyiyemisi C. Damisah, Helen Wang, Shaun E. Gruenbaum, Caroline Ong, Hitten P. Zaveri, Benjamin F. Gruenbaum, Tore Eid,